Ex-FDA chief Robert Califf about HHS Secretary Robert F. Kennedy Jr. — “My primary worry is not the FDA, my worry is the ...

The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.

Peter Gillooly, CEO of The Wellness Company, made a formal complaint to HHS' Office of the Special Counsel and other agencies ...

Researchers say they've discovered an already approved migraine drug that can stop symptoms hours before a severe headache ...

The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...

The head of the FDA reiterated that the agency is applying a more skeptical approach to this year’s round of COVID-19 vaccine boosters.

Robert F. Kennedy Jr. will testify before the House Appropriations Committee and the Senate Health, Education, Labor and Pensions Committee.

Placebo testing has been part of the process since the 1940s. It’s unclear what additional measures would achieve — but it may slow development.

MPox is endemic in DRC, and has continued to cause large numbers of cases in the WHO African Region. In April, 2025, the WHO has restated that MPox continues to be a Public Health Emergency of ...

The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.

The Trump administration has launched a $500 million project to develop a universal flu vaccine that won't need yearly ...

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...